Claude Science is Anthropic’s newest flagship product
MIT Technology Review AI Grace Huckins ● Covered by 3 sources
Anthropic launched Claude Science, a standalone product designed to autonomously conduct scientific research tasks in computational biology and drug development, available to all paid Claude subscribers. The system can execute work comparable to a second-year graduate student and integrates with tools for genetics, chemistry, and protein biology, as demonstrated when it identified drug candidates for phenylketonuria. Anthropic will use Claude Science for its own drug research on neglected diseases while competing with Google DeepMind's dominance in AI for science, particularly after researcher John Jumper recently left DeepMind to join Anthropic.
Why it matters
At an event for pharmaceutical executives, biotech founders, and researchers on Tuesday, Anthropic announced Claude Science, a major new product intended to support scientific research in the same way that Claude Code supports software engineering. Like Claude Code, Claude Science can autonomously carry out meaningful work when given concise, high-level instructions, and it has access…
